on SARTORIUS STED BIO (EPA:DIM)
Presentation of the Capital of Sartorius Stedim Biotech SA
On August 31, 2026, Sartorius Stedim Biotech SA published a statement regarding its share capital, in accordance with the French Commercial Code and the regulations of the AMF (French Financial Markets Authority). Based in Aubagne, France, the company disclosed that its share capital consists of 97,330,405 shares. The total number of theoretical voting rights is 164,770,938, including treasury shares. Furthermore, the total number of net voting rights amounts to 164,733,033. These figures illustrate the company's share capital structure as of the date indicated.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news